Related references
Note: Only part of the references are listed.MiR-539 inhibits thyroid cancer cell migration and invasion by directly targeting CARMA1
Lixue Gu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients
Aleksandra Butrym et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Signaling by exosomal microRNAs in cancer
Germana Falcone et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients
Igor Tsaur et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells
Masanori Kawano et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1
Ying-Qing Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer
Jun Xiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells
Carolina M. Vicente et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway
Minxia Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1
Guang-jun Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
Hongtuan Zhang et al.
ONCOTARGET (2015)
High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
Dong Lin et al.
CANCER RESEARCH (2014)
Expression of RABEX-5 and its clinical significance in prostate cancer
Hongtuan Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells
Jin-Hua He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Multiple functions of hypoxia-regulated miR-210 in cancer
Qin Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
SPAG5 upregulation predicts poor prognosis in cervical cancer patients and alters sensitivity to taxol treatment via the mTOR signaling pathway
L-J Yuan et al.
CELL DEATH & DISEASE (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells
Kathrin Thedieck et al.
CELL (2013)
Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer
Hongtuan Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
Stephen Yiu Chuen Choi et al.
JOURNAL OF PATHOLOGY (2013)
Management of Metastatic Castration-Resistant Prostate Cancer Recent Advances
Deborah Mukherji et al.
DRUGS (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
ERG gene rearrangements are common in prostatic small cell carcinomas
Tamara L. Lotan et al.
MODERN PATHOLOGY (2011)
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
Sean R. Williamson et al.
MODERN PATHOLOGY (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
Gene Expression Profiles of Non-Small Cell Lung Cancer: Survival Prediction and New Biomarkers
Kristjan Vaelk et al.
ONCOLOGY (2010)
SNM1B/Apollo interacts with astrin and is required for the prophase cell cycle checkpoint
Lingling Liu et al.
CELL CYCLE (2009)
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Mohamed S. Arredouani et al.
CLINICAL CANCER RESEARCH (2009)
Tumor immunobiological differences in prostate cancer between African-American and European-American men
Tiffany A. Wallace et al.
CANCER RESEARCH (2008)
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
Sunita R. Setlur et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Astrin is required for the maintenance of sister chromatid cohesion and centrosome integrity
Kerstin H. Thein et al.
JOURNAL OF CELL BIOLOGY (2007)
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
Uma R. Chandran et al.
BMC CANCER (2007)
Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells
PB Liu et al.
CANCER RESEARCH (2006)
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally et al.
CANCER CELL (2005)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)